Literature DB >> 20617468

The case for cardiac magnetic resonance and positron emission tomography multimodality imaging of myocardial viability.

George A Beller.   

Abstract

Mesh：

Year:  2010        PMID： 20617468     DOI： 10.1007/s12350-010-9270-y

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  9 in total

1.  18F-FDG PET imaging of myocardial viability in an experienced center with access to 18F-FDG and integration with clinical management teams: the Ottawa-FIVE substudy of the PARR 2 trial.

Authors:  Arun Abraham; Graham Nichol; Kathryn A Williams; Ann Guo; Robert A deKemp; Linda Garrard; Ross A Davies; Lloyd Duchesne; Haissam Haddad; Benjamin Chow; Jean DaSilva; Rob S B Beanlands
Journal:  J Nucl Med       Date:  2010-03-17       Impact factor: 10.057

2.  Relationship between QRS duration, left ventricular volumes and prevalence of nonviability in patients with coronary artery disease and severe left ventricular dysfunction.

Authors:  Olivier De Winter; Nico Van de Veire; Frederic Van Heuverswijn; Geert Van Pottelberge; Thierry C Gillebert; Johan De Sutter
Journal:  Eur J Heart Fail       Date:  2005-11-21       Impact factor: 15.534

3.  Viability assessment with MRI is superior to FDG-PET for viability: Con.

Authors:  Randolph E Patterson; Steven R Sigman; Robert E O'Donnell; Robert L Eisner
Journal:  J Nucl Cardiol       Date:  2010-04       Impact factor: 5.952

4.  Viability assessment with MRI is superior to FDG-PET for viability: Pro.

Authors:  Jamshid Maddahi
Journal:  J Nucl Cardiol       Date:  2010-04       Impact factor: 5.952

5.  The impact of viability assessment using myocardial perfusion imaging on patient management and outcome.

Authors:  Fadi G Hage; Rajesh Venkataraman; Wael Aljaroudi; Paco E Bravo; Joel McLarry; Michael Faulkner; Jaekyeong Heo; Ami E Iskandrian
Journal:  J Nucl Cardiol       Date:  2010-02-26       Impact factor: 5.952

6.  Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis.

Authors:  Kevin C Allman; Leslee J Shaw; Rory Hachamovitch; James E Udelson
Journal:  J Am Coll Cardiol       Date:  2002-04-03       Impact factor: 24.094

7.  The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction.

Authors:  R J Kim; E Wu; A Rafael; E L Chen; M A Parker; O Simonetti; F J Klocke; R O Bonow; R M Judd
Journal:  N Engl J Med       Date:  2000-11-16       Impact factor: 91.245

Review 8.  Assessment of myocardial viability in patients with heart failure.

Authors:  Arend F L Schinkel; Don Poldermans; Abdou Elhendy; Jeroen J Bax
Journal:  J Nucl Med       Date:  2007-06-15       Impact factor: 10.057

9.  Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study.

Authors:  Anja Wagner; Heiko Mahrholdt; Thomas A Holly; Michael D Elliott; Matthias Regenfus; Michele Parker; Francis J Klocke; Robert O Bonow; Raymond J Kim; Robert M Judd
Journal:  Lancet       Date:  2003-02-01       Impact factor: 79.321
  9 in total
  1 in total

Review 1.  Noninvasive assessment myocardial viability: current status and future directions.

Authors:  Kevin C Allman
Journal:  J Nucl Cardiol       Date:  2013-06-15       Impact factor: 5.952
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.